The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
January 2016 to start new era for pharma companies in Europe
The past decade has witnessed a wave of global transparency in the pharmaceutical industry, and 2015 has marked the start of a new era in Europe. From January 2016, pharma companies will make their transfers of value public to healthcare professionals and healthcare organisations in Europe.
Therefore, Fleming Europe has decided to gather the experts at its 4th edition of Corporate Compliance and Transparency in the Pharmaceutical Industry and make sure that these companies have entered the new year prepared.
On the 24th of February 2016, legal and compliance professionals from Johnson & Johnson, Novo Nordisk, Sandoz, Mylan, Actavis, Boehringer-Ingelheim, GlaxoSmithKline and many more will meet in Zurich to prepare for not only a huge technical challenge but also a major cultural shift.
During the two focused days, attendees will get an update on the Disclosure Code implementation and its first outcomes and learn how to optimise interactions with HCPs and HCOs through a fully compliant and transparent strategy.
Richard Bergstrom, Director General at EFPIA, will open the first conference day with an on-stage interview. Representatives from Novo Nordisk will present their local perspective and lessons learned. The Director General of the European Generic and Biosimilar Medicines Association will outline the Code of Conduct for the European Generic and Biosimilar Medicines Industry.
The second conference day will focus on risk assessment, communication with third parties along with their training and monitoring, internal investigations and the best practices in compliance programme structure and their effectiveness.
If you don't want your ideas to sit and gather dust, join Fleming Europe's 4th edition of Corporate Compliance and Transparency in the Pharmaceutical Industry. You are also welcome to join the discussions in the Pharma SFE & Marketing Forum
Interested in this topic?
12th Project & Portfolio Management in the Pharmaceutical Industry Congress
12th Project and Portfolio Management Congress in Europe presents a high-level meeting looking at the best ways forward in enhanced R&D productivity, forecasting and ultimately, optimizing balance throughout the lifecycle.
Pharmaceutical Cold Chain & Logistics in Latin America
Join professionals from Latin America in a remarkable event that will be a step ahead in your professional career thanks the ultimate knowledge and insights shared in these two days.
5th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform to discuss compliance and transparency areas of key concern. Goal is to unravel compliance challenges, define and learn fair market value and develop a consistent, simple and transparent method and strategy for your company.
Interview: A holistic approach to the strategic planning process
Read the full interview with Ken Dobie, Founder & Principal of Skyemar Consulting, Former Director, Corporate Planning & Portfolio Management, Illumina and gain the insight into the aligning strategic priorities to portfolio management and associated resources.
Interview: East vs. West – Is there a regional approach to PPM in the US?
Read the full interview with Leigh Shultz, PhD, PMP, Associate Vice President, Project Management – Primary Care, Infectious Disease, Vaccines, Global Project & Alliance Management, Merck and gain insight into the regional approach to PPM across the US.
Interview: Project & Portfolio Management for Pharma & Biotech
Read the full interview with Eric Towler, Therapeutic Area Lead, BioPharma Project Management, Bristol-Myers Squibb and gain insight into the latest PPM trends.